Title : Pharmacogenetics of novel glucose-lowering drugs.

Pub. Date : 2021 Jun

PMID : 33594477






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The aim of this work was to review studies in which genetic variants were assessed with respect to metabolic response to treatment with novel glucose-lowering drugs: dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2i). Glucose dipeptidyl peptidase 4 Homo sapiens